Global needs drive growth of pharmaceutical industry – Market Realist #top #generic #pharmaceutical #companies

Posted On Jun 14 2017 by

#pharmaceutical industry growth # Global needs drive growth of pharmaceutical industry Aging population Worldwide, the average human life span has increased substantially over the last few decades. However, more infections and diseases have come along with this longevity growth. This has led to increased research on aging populations. The goals are to prevent infections and maintain health so that these populations can enjoy better lives. Changing lifestyles Hectic daily schedules have led to unhealthy eating habits, a lack of exercise, less sleep, and other problematic lifestyle choices. This has resulted in high obesity rates, poor digestion, hallucinations, breathing difficulties, and …


Pharmaceutical Industry Trends, Analysis, Statistics – Market Growth #contract #pharmaceutical #manufacturing

Posted On Jun 14 2017 by

#pharmaceutical industry growth # Pharmaceutical Industry Analysis: Latest Market Research Reports Topics under Pharmaceutical Global Pharmaceutical Industry Overview The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics. The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013. The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics …


Pharmaceutical Industry Growth Rebounds in Five-Year Outlook #italian #pharmaceutical #companies

Posted On Jun 14 2017 by

#pharmaceutical industry growth # Global spending on medicines is expected to meet the $1 trillion threshold in 2014 and reach $1.2 trillion by 2017, according to a recent report by the IMS Institute for Healthcare Informatics. The report, The Global Use of Medicines: Outlook through 2017, found that growth in global spending on medicines increased 2.6% to $965 billion in 2012, and is forecast to grow at a 3 6% compound annual rate over the next five years. IMS projects a gradual increase in global medicine spending growth during the next five years. Annual growth in spending is expected to …


Strong Growth Ahead for Contract Manufacturing #lgm #pharma

Posted On Jun 10 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 #acceleron #pharma

Posted On May 15 2017 by

#lupin pharma # Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 Sohini Das | Ahmedabad Jan 19, 2016 10:01 AM IST Looking to add $1 billion in revenues from inorganic growth to reach its target turnover of $5 billion by 2018, pharma giant Lupin, which is currently worth $2 billion, says it is open to late stage speciality assets. Lupin s chief financial officer Ramesh Swaminathan told Business Standard that while $200-300 million per acquisition is a sweet spot for the company historically, it does not mean that the company won t look at bigger acquisitions. …


India – s Pharmaceutical industry is on a good growth path, but will have to

Posted On May 14 2017 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …


Strong Growth Ahead for Contract Manufacturing #pharmajob

Posted On May 3 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #pharma #times

Posted On Apr 21 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


Strong Growth Ahead for Contract Manufacturing #pharma #market #research

Posted On Apr 15 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #avalon #pharma

Posted On Apr 11 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …